Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. - Wikidata - wikimedia - TriplyDB

Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.

Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.

http://www.wikidata.org/entity/Q51642133

about

Transarterial radioembolization for hepatocellular carcinoma: a review Hepatocellular carcinoma in elderly patients: challenges and solutions Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review Current status of transarterial radioembolization Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinoma Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments Management of hepatocellular carcinoma with portal vein thrombosis The role of interventional radiology in the management of hepatocellular carcinoma Yttrium-90 radioembolization of liver tumors: what do the images tell us?Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective Systematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directions Cancer concepts and principles: primer for the interventional oncologist-part II Hepatocellular Cancer: New Kids on the Block Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives A Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular Carcinoma Selective Internal Radiation Therapy (SIRT) as Conversion Therapy for Unresectable Primary Liver Malignancies Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016 A systematic review on the safety and effectiveness of yttrium-90 radioembolization for hepatocellular carcinoma with portal vein tumor thrombosis Update in management of hepatocellular carcinoma in Eastern population Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres Locoregional treatment for hepatocellular carcinoma: The best is yet to come.Hepatic arterial infusion chemotherapy with fine-powder cisplatin and iodized-oil suspension in patients with intermediate-stage and advanced-stage (Barcelona Clinic Liver Cancer stage-B or stage-C) hepatocellular carcinoma: multicenter phase-II cli Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization.Radioembolization of hepatic tumors Radioembolization for the treatment of hepatocellular carcinoma Survival analysis of transarterial radioembolization with yttrium-90 for hepatocellular carcinoma patients with HBV infection.New progress of non-surgical treatments for hepatocellular carcinoma.Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial.Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinoma.Intermediate hepatocellular carcinoma: How to choose the best treatment modality?Hong Kong consensus recommendations on the management of hepatocellular carcinoma.Yttrium-90 microsphere radioembolization for hepatocellular carcinoma.Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis.Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization.Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis.

P2860

Q26738273-0B17DB5C-39B7-4B79-8058-10F69667B035 Q26738274-E9542909-1F1A-4AFF-A936-36A2184E5276 Q26743603-785699B2-3FBE-416A-9350-FF45C59E1722 Q26744307-9B1C0DCE-7A7C-4313-B4AA-06F4453D1286 Q26753089-F47B1365-0527-4AAF-8A4D-69D3CFAE0B87 Q26766707-FADD3A83-F919-4721-B4E9-19768BDCC409 Q26783881-8FE882D9-B7F0-4551-9843-734EBBAE1110 Q26852174-15E0D527-AD77-4F49-BA80-FB69F4137583 Q26996578-CA3E826D-B181-4FB9-BA24-82173D81F7BB Q26996805-088C8C5B-D59F-46A6-BFC1-E48CAB0E5BE1 Q26997064-6E7C3831-EBCE-4600-A11E-B688A039F834 Q26998606-D27D1ACA-1E1E-4FC2-A2E6-D3846114A741 Q26998661-096D1B15-5F9B-4C9B-AAE0-07A281CE7AD0 Q27007847-CCDFAD09-D641-4FB7-A8EE-84198A2888E6 Q27010961-8F768C0F-7269-4262-94EE-9B7795A15E5B Q27022642-94F7AE1C-3C17-482B-BC13-D93950911E2B Q27023616-964991F2-3C4A-49D9-BF79-6F6B5C51B287 Q28067517-B8B9E6AA-43EE-4657-AA1B-4F2D4C5CF12B Q28071594-A2711705-C6B8-4C7F-955D-EFD576705F5E Q28072595-3A5DB9C6-7087-49B4-897A-93C7E91DB627 Q28079066-EA0BC181-4187-4302-8DA6-CF5EEFD43283 Q28080480-A3041991-8A49-45E7-97DC-F8BDD87CADAF Q28081783-7580426A-37CA-4350-AF70-461AA9BFD233 Q28083185-40BA4152-12DD-443C-8061-D48219BC216B Q30400312-EA175B91-A1E8-4358-A45E-28F89C1572B1 Q33418923-715791DA-7CDA-48BA-861D-6BED02A25F9A Q33797067-64D3F46B-A7C3-4B99-B589-71E205B0CB13 Q33820777-F4F55108-1C6C-4CA2-A066-507A66D8A44C Q33872976-59A6A3AB-E5B1-4B70-9889-3598650E6EFD Q34077181-519EC922-515E-43D4-AD69-3F0F7F77F5B2 Q34647076-8AFEADBA-C2D9-4B37-A609-83E828681E66 Q34695917-197518A8-8F3C-47EB-B041-0338485F8AE2 Q35164855-B16D5EBF-5D9B-44BC-8E16-B2EE7417B450 Q35626764-681A28EC-DA1F-4232-89EB-30A01EC74898 Q35631295-EC2D961C-4F06-4FE5-AC51-5579FA6EE65F Q35631304-27F0CB2C-1638-4924-A33B-A08BDD09CB13 Q35715947-54A86DEE-ED74-45F0-B465-49D8D310C07B Q35824064-0DF8ECC8-72DA-4BB8-8F6D-072D70828F65 Q35888586-69CEE45D-D2E4-4199-AA3A-EB4BE48D8E3D Q36009432-A3015C42-6176-4A8B-A080-7524429C96AC

P2860

Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.

http://www.wikidata.org/entity/Q51642133

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Radioembolization with yttrium ...... safety and long-term survival.

@en

Radioembolization with yttrium ...... safety and long-term survival.

@nl

type

label

Radioembolization with yttrium ...... safety and long-term survival.

@en

Radioembolization with yttrium ...... safety and long-term survival.

@nl

prefLabel

Radioembolization with yttrium ...... safety and long-term survival.

@en

Radioembolization with yttrium ...... safety and long-term survival.

@nl

P1433

Q51642133-B10D0BC5-2DD6-47C5-9838-E2FB9B154E8E

P1476

Q51642133-6906859B-856D-4747-A169-7C6975733DB0

P2093

Q51642133-08E42E01-72DC-42E1-9F0D-802B16BBE2A8

Q51642133-563EAFE9-9EF4-4E5F-8932-044479EB59B1

Q51642133-6A0E9761-AEF7-4721-B7D6-E97DA719954A

Q51642133-76E1178C-18B0-46B2-AC89-8779307059BD

Q51642133-7AF1D8CB-C958-473F-B20E-005AA3A0F7C7

Q51642133-9765E34D-8A93-4C02-B232-8BAC147C0A4C

Q51642133-C4827872-B6BA-4FD5-A2AE-AD9124DA0D47

Q51642133-C616289C-CA0B-4728-A8BA-D043A01F2CC3

Q51642133-EA0E2346-5244-4815-B597-61F3A2497FCD

P2860

Q51642133-13E3762D-2011-494A-84E3-3230807928BB

Q51642133-D14D5A59-6D43-46CF-A449-99CF942F67F9

Q51642133-E56C712C-4046-4B37-9ADA-A520F786C1D6

Q51642133-ED4658BF-F7E2-404B-84DC-E11CE461AFB3

P304

Q51642133-AFBB2C6E-26FC-4A64-B0D8-0752CA5E7C15

P31

Q51642133-1CAA0B1E-A276-4FA5-8C0B-838BEF954EED

P356

Q51642133-55D7FD5E-FD44-4E56-A201-236F6AA42D3B

P407

Q51642133-292F1580-226D-4926-8124-6290131D9866

P433

Q51642133-373A8E2E-597A-4A8F-8D1A-D6B3A4C12965

P478

Q51642133-2ADC3EB6-A17A-437A-90B3-CB4F4AC743C3

P50

Q51642133-110519B2-28C3-4C8B-8D40-7AEC8C09BE34

Q51642133-77B67997-3D77-4816-B92F-8149D9175FEA

Q51642133-CB638DEE-944D-46E8-BE99-4E5893D9CA33

P577

Q51642133-BA23A8C1-0A89-46DD-A942-19A8377F544C

P5875

Q51642133-9F756B93-75D6-4900-A0A4-994029E0F929

P698

Q51642133-2529DC95-8122-4BB4-8886-254EB09DCA02

P921

Q51642133-96D72B0D-7E6E-41DA-8776-F40E6671C0F2

P356

P1433

P1476

Radioembolization with yttrium ...... safety and long-term survival.

@en

P2093

Amr El Fouly

http://www.w3.org/2001/XMLSchema#string

Andreas Paul

http://www.w3.org/2001/XMLSchema#string

Gerald Antoch

http://www.w3.org/2001/XMLSchema#string

Judith Ertle

http://www.w3.org/2001/XMLSchema#string

Monia Hamami

http://www.w3.org/2001/XMLSchema#string

Philip Hilgard

http://www.w3.org/2001/XMLSchema#string

Stefan Müller

http://www.w3.org/2001/XMLSchema#string

Till Heusner

http://www.w3.org/2001/XMLSchema#string

Vito R Cicinnati

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.

Staging systems in hepatocellular carcinoma.

Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.

Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.

P304

1741-1749

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.23944

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

Andreas Bockisch

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47637084

http://www.w3.org/2001/XMLSchema#string

P698

21038413

http://www.w3.org/2001/XMLSchema#string

P921